SCM

Silverarc Capital Management Portfolio holdings

AUM $691M
1-Year Est. Return 223.03%
This Quarter Est. Return
1 Year Est. Return
+223.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$489M
AUM Growth
+$9.97M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
83
New
Increased
Reduced
Closed

Top Buys

1
+$14.1M
2
+$12.1M
3
+$11.4M
4
PCVX icon
Vaxcyte
PCVX
+$9.36M
5
URGN icon
UroGen Pharma
URGN
+$8.79M

Top Sells

1
+$17.7M
2
+$15.5M
3
+$11.7M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$8.49M
5
WVE icon
Wave Life Sciences
WVE
+$8.49M

Sector Composition

1 Healthcare 100%
2 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GUTS icon
51
Fractyl Health
GUTS
$173M
$328K 0.06%
202,590
-34,858
BDSX icon
52
Biodesix
BDSX
$63.6M
$302K 0.06%
53,518
-151,402
SGMT icon
53
Sagimet Biosciences
SGMT
$252M
$286K 0.05%
+37,539
ELVN icon
54
Enliven Therapeutics
ELVN
$1.31B
$201K 0.04%
+10,000
CNTA
55
Centessa Pharmaceuticals
CNTA
$3.71B
$65.7K 0.01%
5,000
-227,758
NKTR icon
56
Nektar Therapeutics
NKTR
$1.15B
$8.94K ﹤0.01%
+346
RCKTW icon
57
Rocket Pharmaceuticals Warrant
RCKTW
$3.02K ﹤0.01%
104,828
XENE icon
58
Xenon Pharmaceuticals
XENE
$3.15B
– –
-10,121
ABVX
59
Abivax
ABVX
$8.59B
– –
-210,901
ALKS icon
60
Alkermes
ALKS
$4.8B
– –
-124,871
AVDL
61
Avadel Pharmaceuticals
AVDL
$2.3B
– –
-39,366
BBIO icon
62
BridgeBio Pharma
BBIO
$12.8B
– –
-111,000
BPMC
63
DELISTED
Blueprint Medicines
BPMC
– –
-37,345
CAPR icon
64
Capricor Therapeutics
CAPR
$256M
– –
0
CCCC icon
65
C4 Therapeutics
CCCC
$239M
– –
-882,300
CCOI icon
66
Cogent Communications
CCOI
$862M
– –
0
GILD icon
67
Gilead Sciences
GILD
$155B
– –
-62,029
HIMS icon
68
Hims & Hers Health
HIMS
$8.42B
– –
0
IFRX icon
69
InflaRx
IFRX
$91.5M
– –
-1,161,567
IRON icon
70
Disc Medicine
IRON
$3.4B
– –
-236,471
KALA icon
71
KALA BIO
KALA
$4.96M
– –
-246,079
KURA icon
72
Kura Oncology
KURA
$975M
– –
-581,369
LQDA icon
73
Liquidia Corp
LQDA
$2.44B
– –
-214,057
MDGL icon
74
Madrigal Pharmaceuticals
MDGL
$12B
– –
-10,344
OCUL icon
75
Ocular Therapeutix
OCUL
$2.41B
– –
-551,570
1 2
3
4